Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality. - Wikidata - wikimedia - TriplyDB

Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality.

Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality.

http://www.wikidata.org/entity/Q37383747

about

Transcriptional regulation of the 5-HT1A receptor: implications for mental illness Higher in vivo serotonin-1a binding in posttraumatic stress disorder: a PET study with [11C]WAY-100635 Serotonin-1A receptor alterations in depression: a meta-analysis of molecular imaging studies.Molecular imaging for depressive disorders.Molecular, Functional, and Structural Imaging of Major Depressive Disorder.Brain serotonin 1A receptor binding as a predictor of treatment outcome in major depressive disorder.Effects of early-life stress on serotonin(1A) receptors in juvenile Rhesus monkeys measured by positron emission tomography Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression.Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations F15599, a highly selective post-synaptic 5-HT(1A) receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity.The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants.Enhanced 5-HT1A receptor-dependent feedback control over dorsal raphe serotonin neurons in the SERT knockout mouse Familial risk for major depression is associated with lower striatal 5-HT₄ receptor binding Cortical shape and curvedness analysis of structural deficits in remitting and non-remitting depression.5-HT₁A receptor binding is increased after recovery from bulimia nervosa compared to control women and is associated with behavioral inhibition in both groups Positron emission tomography quantification of serotonin(1A) receptor binding in suicide attempters with major depressive disorder.Transcriptional dys-regulation in anxiety and major depression: 5-HT1A gene promoter architecture as a therapeutic opportunity.Treatment of depressive-like behaviour in Huntington's disease mice by chronic sertraline and exercise.Genetic Variations in the Serotonergic System Mediate a Combined, Weakened Response to SSRI Treatment: A Proposed Model(1,2)Positron emission tomography quantification of serotonin transporter binding in medication-free bipolar disorder.Imaging the serotonin 1A receptor using [11C]WAY100635 in healthy controls and major depression Antidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorder Quantification of the Serotonin 1A Receptor Using PET: Identification of a Potential Biomarker of Major Depression in Males Positron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorder Impact of Depression and Inflammation on the Progression of HIV Disease.The 5-HT1A receptor in Major Depressive Disorder Oestrogen: an overlooked mediator in the neuropsychopharmacology of treatment response?Serotonin: imaging findings in eating disorders.Molecular imaging in patients with mood disorders: a review of PET findings.Serotonin and molecular neuroimaging in humans using PET.Molecular Neurobiology of Depression: PET Findings on the Elusive Correlation with Symptom Severity.The influence of the rs6295 gene polymorphism on serotonin-1A receptor distribution investigated with PET in patients with major depression applying machine learning.Prediction of selective serotonin reuptake inhibitor response using diffusion-weighted MRI.Regulatory Pathways of Monoamine Oxidase A during Social Stress.Will imaging individual raphe nuclei in males with major depressive disorder enhance diagnostic sensitivity and specificity?Evaluation of peripheral serotonin content and α2-adrenergic receptor function as potential markers for life-long recurrent depressive disorder by using methodological improvements.Quantification of 5-HT1A and 5-HT2A Receptor Binding in Depressed Suicide Attempters and Non-Attempters.A positron emission tomography study of the serotonergic system in relation to anxiety in depression.Different patterns of 5-HT receptor and transporter dysfunction in neuropsychiatric disorders--a comparative analysis of in vivo imaging findings.Measuring endogenous changes in serotonergic neurotransmission in humans: a [11C]CUMI-101 PET challenge study.

P2860

Q26999691-CFD7E93E-3C4C-4B1B-8255-DB6B5FCC2B45 Q28389170-A001B888-0525-478F-9E7A-A85707B67ED1 Q30245389-5B73EAC1-B94F-4876-92AC-EBE547C0AF43 Q30821361-51F59058-E77C-42AB-A5EC-AEC0A460CC05 Q31090058-B75E4C9E-A8B3-47C7-B9C4-0F5B797ACA7F Q33792011-DCC1BDFC-1521-4B63-8D38-8CE615187C98 Q33900907-25B25CF9-A6FA-4B8C-B7CD-B7FE44D505F7 Q33961770-2044135A-9852-410C-BFFA-C65C475DFA80 Q33976272-DD336530-436C-49A7-AF09-4FE1FC66FC3B Q34091711-E7B1B020-DCC4-4726-83A3-8EA9EA81BBF2 Q34497909-A5DFA8FF-8640-4A85-A8A5-741A066B7FD3 Q34603228-E5F0385E-DBE3-46E1-AFDA-3616E96FAEE3 Q34667157-4B164685-F9FA-4A9D-A9E6-77E5030506D7 Q34849885-DAE67B05-FF29-4625-A490-48851E1E6411 Q34856647-EC1BBD7B-C3BB-47AA-97D9-A877449D093D Q35087781-8D9C836B-8FCC-404C-AE84-7EAFA4F12C16 Q35887986-31BF1BE0-590C-4213-8100-5AAEC84C1626 Q36024880-0066550B-5CB2-493C-8DFC-51E2F2FC1C38 Q36103263-CB30B8A5-4A52-465C-A62C-154E59AD802B Q36303529-EF08D27A-63ED-47D8-B14B-38E1DD3D73AB Q36801178-5E3E13F6-11D2-4D02-A4CB-D3E7D1F4799D Q36948231-D20CAEF9-5281-441B-BD55-73E2A274AA2A Q37024830-092DE394-CC61-4FAB-89E9-683F8D9ECF9F Q37049887-A72EEF84-D3CF-472F-B7F7-7C5E373303C6 Q37138606-FAE71D94-A628-40D5-A753-5FC69AA6305A Q37538381-14189379-0D27-47BF-8E2E-3E63FAF781D7 Q37791238-B9FCB177-E7FB-41E7-8FCC-B944DDB1AADD Q37829680-1F6A906B-A622-415A-A30C-E8496C39C9F8 Q37864156-42B6F2C0-28F3-4FE3-8B6D-70AE1EDC1E84 Q37938794-74B467C0-6187-4B6B-BE1A-C1FFF864702E Q38086422-E156329A-0082-4BE5-A805-3E293EAB57DC Q38671559-BCF67D48-F85A-4421-993B-D70847A8F325 Q41551746-FAEB59B6-A7B5-4E4D-B809-4360976DC22E Q47171927-FCCB95FC-A6BD-4ACB-BE1E-FAFE165E6488 Q47557026-06790D3B-0202-4FD0-BBDB-DE7D51FEDBCF Q47584940-D20276B5-E643-4D6A-BE41-AB8589908C63 Q47667959-DCA03318-169D-47FE-B9D1-07EFA9032032 Q47724853-109F9A79-AEC5-44CA-A1CD-2550A95235A4 Q48074706-4EF12290-B021-4C76-B0BE-286421B754EF Q48483797-3C3121B4-D997-4902-A241-B1BE5E9AC516

P2860

Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality.

http://www.wikidata.org/entity/Q37383747

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Elevated serotonin 1A binding ...... trait biological abnormality.

@en

Elevated serotonin 1A binding ...... trait biological abnormality.

@nl

type

label

Elevated serotonin 1A binding ...... trait biological abnormality.

@en

Elevated serotonin 1A binding ...... trait biological abnormality.

@nl

prefLabel

Elevated serotonin 1A binding ...... trait biological abnormality.

@en

Elevated serotonin 1A binding ...... trait biological abnormality.

@nl

P1433

Q37383747-3FE53836-E526-4E85-9C27-0E8D8118C65E

P1476

Q37383747-66BA007E-52A2-49C3-813C-BAD9387F226E

P2093

Q37383747-0067189A-83C5-4DE3-B74F-D47C80D962A3

Q37383747-2E92CCE2-071B-45DF-B17A-EBF9049CEF03

Q37383747-350FF4EA-35CF-41A6-9CFD-9B8296568D9C

Q37383747-4C0F8E68-7B72-4D95-86A8-8F8F3A041B1F

Q37383747-A44EE8F5-AE98-43E2-A11A-C808E405C26E

Q37383747-D9F6568D-6A1A-4D7A-AEFE-A235E21BC72E

P2860

Q37383747-00006439-4A32-47CA-AC16-220F42F269C6

Q37383747-051B40BF-D644-421F-9A72-33623293125D

Q37383747-082F4104-2897-42AC-9EC7-09B1E4636DBA

Q37383747-0A947086-A6CA-4CB1-9CBE-87830C0448A1

Q37383747-0AD1D974-4CDE-4BE4-865F-31C92A60820C

Q37383747-139A9BBA-3D91-42D7-B27C-36D22624E316

Q37383747-1ADD17A3-B720-4618-98FC-3A70631B5E88

Q37383747-1B3263AA-A4FA-403E-BB60-688B38A3CEE5

Q37383747-1D99C09B-7431-42DD-8DB0-40CF42D9A86B

Q37383747-22B6ABB2-7CBD-49AB-8A80-3B108366B423

P2888

Q37383747-2B32A982-F9D4-41FB-82CA-38EC9A784AC1

P304

Q37383747-F7EBD996-336F-415F-AA26-8413D75A040B

P31

Q37383747-E5D20883-F2E8-4060-9503-8463AEF042B3

P356

Q37383747-5268B7C2-7C5A-4137-AB29-A826EE51D2B3

P407

Q37383747-710639DF-30CA-429B-84D0-10A56F82F9D9

P433

Q37383747-395AD540-EEFF-4F35-BAB8-A190BFE94257

P478

Q37383747-8C3AC72B-B316-4426-BD72-FECC8A5F72CC

P50

Q37383747-A3E33475-F598-465F-8920-F951E8E9312B

P577

Q37383747-B191D0A3-6030-4306-BB00-835085243BEA

P5875

Q37383747-CF6F4CC1-159E-473F-8F7E-33A7843B713D

P6179

Q37383747-5B1F4A2F-BF0B-4D9E-8E8E-38CB2277AED6

P698

Q37383747-7DC3ACDE-8FCA-4892-9C62-1842A1856A89

P921

Q37383747-a80bc635-4a8c-42bc-b10a-0d9bca80d615

P932

Q37383747-7FB749A1-D809-49B2-9620-DC1323E98C01

P356

P1433

Neuropsychopharmacology

P1476

Elevated serotonin 1A binding ...... trait biological abnormality.

@en

P2093

Gregory M Sullivan

http://www.w3.org/2001/XMLSchema#string

J John Mann

http://www.w3.org/2001/XMLSchema#string

Jeffrey M Miller

http://www.w3.org/2001/XMLSchema#string

Kathleen G Brennan

http://www.w3.org/2001/XMLSchema#string

Ramin V Parsey

http://www.w3.org/2001/XMLSchema#string

Todd R Ogden

http://www.w3.org/2001/XMLSchema#string

P2860

A rating scale for depression

Serotonin-1A receptor imaging in recurrent depression: replication and literature review

PET imaging of serotonin 1A receptor binding in depression

A database of [(11)C]WAY-100635 binding to 5-HT(1A) receptors in normal male volunteers: normative data and relationship to methodological, demographic, physiological, and behavioral variables

Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

Fast robust automated brain extraction

A global optimisation method for robust affine registration of brain images

P2888

P304

2275-2284

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NPP.2009.54

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

Maria A Oquendo

P577

2009-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24442816

http://www.w3.org/2001/XMLSchema#string

P6179

1041832790

http://www.w3.org/2001/XMLSchema#string

P698

19458612

http://www.w3.org/2001/XMLSchema#string

P921

P932

2760406

http://www.w3.org/2001/XMLSchema#string